Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

European fund of funds to grow by $250bn, multi asset absolute return managers to lead the pack - Cerulli

Friday, September 10, 2010
Opalesque Industry Update - According to The Cerulli Report: European Funds of Funds, the European FOF sector will expand by almost €250 billion by 2014. The winners in the race to capture assets will be multi-asset absolute-return managers and aggressive FOF asset allocators.

Consolidators with the resources, economies of scale, and asset class firepower to run FOFs well will also increase their marketshare. Others will be less fortunate. Too many of Europe's FOFs are poorly designed, struggle with compliance risk, and have failed to attract sufficient assets to be tenable in the long term.

European FOF assets have recovered from the lows of 2008, although Mediterranean markets still suffer from poor sentiment and fund outflows. European assets under management (AUM) will rise from €319.7 billion at the end of 2009 to an estimated €567.5 billion by the end of 2014, a compound annualized growth rate (CAGR) of 12.2%. Paul Burgin, the primary author of the report, says: "Whilst the European picture looks good overall, there are distinct variations in the outlook for each country. The European Union product and distribution landscape is still fragmented as most FOF providers only distribute in home territory."

France is Europe's largest FOF market, yet offers the weakest growth forecast at 8.4% per annum. "The outlook would be rosier if fund groups stopped including too many of their own funds in supposedly open-architecture FOF portfoliosm," said Shiv Taneja, managing director at Cerulli Associates.

"French asset managers may find more potential overseas than at home. Their cross-border ranges could tap the underdeveloped Asian FOF market to good effect," he added.

Regulation is driving change in Italy and the U.K., but in very different directions. Italy's strict interpretation of the Markets in Financial Instrument Directive (MiFID) makes it hard to sell FOFs with their double layers of fees. FOFs could eventually die out. International fund groups must focus their attention on segregated account structures that act as a bespoke alternative.... (press release) Corporate website: Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its